Stock Based Compensation	6 Months Ended
Jun. 26, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation	8. Stock Based Compensation During the quarter and six months ended June 26, 2020, the Company issued 71,997 and 628,601 restricted stock units, respectively, at a weighted average grant-date fair value of $13.42 and $15.50 per share, respectively. As of June 26, 2020, the Company had 1,238,577 restricted stock units outstanding at a weighted average grant-date fair value of $16.56 per share. As of June 26, 2020, $15.5 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.5 years. As of June 26, 2020, the Company had 81,407 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $18.13 per share. As of June 26, 2020, $1.0 million of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.2 years. Forfeitures for all of the Company’s outstanding equity awards are recognized as incurred.

Stock Based Compensation

6 Months Ended

Jun. 26, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

8. Stock Based Compensation

During the quarter and six months ended June 26, 2020, the Company issued 71,997 and 628,601 restricted stock units, respectively, at a weighted average grant-date fair value of $13.42 and $15.50 per share, respectively. As of June 26, 2020, the Company had 1,238,577 restricted stock units outstanding at a weighted average grant-date fair value of $16.56 per share. As of June 26, 2020, $15.5 million of total restricted stock unit compensation expense related to unvested awards had not been recognized and is expected to be recognized over a weighted average period of approximately 2.5 years.

As of June 26, 2020, the Company had 81,407 shares of common stock subject to vesting requirements outstanding at a weighted average grant-date fair value of $18.13 per share. As of June 26, 2020, $1.0 million of compensation expense related to common stock subject to vesting requirements had not been recognized and is expected to be recognized over a weighted average period of approximately 1.2 years.

Forfeitures for all of the Company’s outstanding equity awards are recognized as incurred.